The KDELR2 gene helps your cells send certain proteins back to the place where they are folded and checked, which supports normal collagen building. When this gene does not work properly, collagen handling can break down and cause a rare inherited form of brittle bone disease called osteogenesis imperfecta. People with harmful variants may have frequent fractures, bone changes, short stature, and sometimes dental problems.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they happen, and how strongly they operate. As a group, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this subject in more detail, you can read more in the LearnHub.
Overview
KDELR2Gene function
What if the gene works
The KDELR2 gene helps move certain proteins back to the part of the cell that prepares and folds proteins. This supports normal protein handling and the cell’s internal transport system.
Risk
What if the gene does not work
More disruptive variants in the KDELR2 gene can cause a form of osteogenesis imperfecta, leading to fragile bones, repeated fractures, short stature, and sometimes spine curvature or hearing changes. Milder variants may cause less severe features or later presentation.
Treatment
What does that mean for your treatment
No KDELR2-specific treatment or drug selection approach is currently established. Care is guided by the person’s symptoms and standard management for the related condition, rather than by a pathogenic variant in the KDELR2 gene itself.
Gene function
What if the gene works
Inside your cells, the KDELR2 gene helps keep the early protein shipping system organized. It works between the endoplasmic reticulum, where many proteins are folded, and the Golgi, which sorts and sends them on. When this system runs smoothly, important helper proteins stay in the right place.
Its protein recognizes helper proteins that have moved from the cell’s protein folding area into its shipping center. It reads a short return label on them and helps send them back.
By bringing these helper proteins home, the KDELR2 gene supports protein folding and early quality checks. This helps newly made proteins take shape before they move to their next destination.
The KDELR2 gene helps keep two way traffic organized between the endoplasmic reticulum and Golgi. That is part of how the KDELR2 gene helps move proteins inside cells and support routine cell function.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. At times, though, a variant can change how a gene works more clearly and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
KDELR2 gene variants can change the shape or stability of this cell transport protein, so it cannot properly return key collagen helper proteins to the right place inside the cell. Research on how KDELR2 gene variants affect collagen processing shows that milder variants may leave some activity, while more severe variants can sharply reduce or stop it. This often disrupts collagen handling, and in people with KDELR2-related osteogenesis imperfecta, stronger functional effects may be linked to earlier or more marked bone fragility.
How variants are linked to conditions
Pathogenic variants in both copies of the KDELR2 gene can cause a rare form of osteogenesis imperfecta, a condition marked by fragile bones and repeated fractures. In people with KDELR2 gene variants and osteogenesis imperfecta, doctors may also see short stature, spinal curvature, and other bone changes. This gene-condition link is established in affected families reported in the medical genetics literature.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found across the population. Most do not directly affect health and simply contribute to normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the KDELR2 gene. If a KDELR2 change is found, overall risk usually depends most on the exact genetic change and family history, and a doctor or genetic counselor can help explain what that means for you.
Inheritance of KDELR2 variants
KDELR2-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one KDELR2 gene variant from each parent, and both parents are typically healthy carriers. For families looking into the inheritance of KDELR2 gene variants, when both parents carry a variant, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of a child who is a carrier, and a 25% chance of a child with no inherited variant. Mothers and fathers pass these variants on equally.
What does my KDELR2 result mean for my family?
For families affected by a KDELR2-related condition, the pattern is usually recessive, which means parents are often healthy carriers and siblings may also be carriers or, less often, affected. Brothers and sisters may want to learn whether they carry the family’s KDELR2 change, especially when planning children. More distant relatives can sometimes carry the same change as well.
Genetic information
Genetic testing
How you find out about variants
KDELR2 genetic testing looks for variants in the KDELR2 gene using a blood sample, saliva sample, or sometimes a cheek swab. Labs usually read the gene’s DNA with sequencing, often as part of a broader bone fragility panel or exome test, and results may show two pathogenic variants, one variant, or no relevant finding.
When should I consider getting a genetic test?
Genetic testing for the KDELR2 gene may be considered when a child or adult has signs of a brittle bone condition, such as repeated fractures, bowed bones, very low bone density, or poor growth, especially if these started early in life. It can also help clarify the cause when there is a family history of a severe inherited bone condition.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains varies depending on the condition and the kind of variant. Other factors, including lifestyle, environment, age, and medical history, also influence how the body functions over time. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, so the same dose can lead to different levels in the body. This is a common reason one treatment may help one person more than another or may cause more side effects in some people. Medication response also depends on age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences affect how people respond to medicines. It studies links between genes and medications to help explain why the same treatment can work differently in different people. For many drugs, genes influence either how strongly a medicine works or how the body handles it. This understanding can support treatment choices that are more informed and tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the KDELR2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how doctors choose medicines, so questions about treatment, side effects, or new health changes are best discussed with your doctor.